DHA Clinical Support Staff Protocol (CSSPs) -- Adult Cold [Final
1. Where can the current DHA CSSPs be found? - d) All of the above 2. According to Up-to-Date, "Major side effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers," what do Angiotensin-converting enzyme (ACE) inhibitors commonly treat (Ref UptoDate)? - b) Hypertension 3. Where can the DHA guidance for peer review be found? - c) DHA-PM 6025.13, (Volume 4) 4. What two patient identifiers should be used to verify a patient’s identity (Ref: TJC & AFI 44-119)? - b) Full Name and Date of Birth 5. According to UptoDate, “The common cold in adults: Treatment and prevention,†what is guaifenesin commonly used to treat (Ref: UptoDate)? - d) Acute Cough 6. What is the meaning of malaise? - b) Fatigue/tired 7. A 36 y/o old male presents to the clinic with a runny nose, congestion, chills and sore throat. Your examination findings are as follows: blood pressure 127/86, pulse 101, respirations 20, temperature of 101.2F, and a rash on their chest. According to the Adult Cold CSSP, what is your next step? - c) Notify the provider for a plan of care based on the exclusionary or differential criteria 8. Which of the following is NOT differential criteria for the Adult Sore Throat CSSP? - b) Fever more than 48 hours 9. A 48 y/o female presents to the clinic with a post-nasal drip, sneezing, and ear pressure. Your examination findings are as follows: blood pressure 127/73, pulse 87, respirations 20, temperature of 98.3F, and productive cough for one week. According to the Adult Cold CSSP, what is your n
Written for
- Institution
- DHA Clinical Support Staff Protocol
- Course
- DHA Clinical Support Staff Protocol
Document information
- Uploaded on
- January 12, 2023
- Number of pages
- 2
- Written in
- 2022/2023
- Type
- Exam (elaborations)
- Contains
- Answers
Subjects
-
1 where can the current dha cssps be found d all of the above 2 according to up to date
-
major side effects of angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers